Characterization of PSA at death in patients with metastatic castration-resistant prostate cancer.

被引：1
|
作者：
Bikkasani, Krishna
Qin, Qian
Lin, Justin
Galsky, Matt D.
Liaw, Bobby Chi-Hung
Oh, William K.
Tsao, Che-Kai
机构：
[1] Icahn Sch Med Mt Sinai, Div Hematol & Med Oncol, Tisch Canc Inst, New York, NY 10029 USA
[2] CUNY, Sch Med, New York, NY 10031 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 07期
关键词：
D O I：
10.1200/JCO.2019.37.7_suppl.184
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
184
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Beyond PSA: Managing Modern Therapeutic Options in Metastatic Castration-Resistant Prostate Cancer
    Karzai, Fatima H.
    Madan, Ravi A.
    Figg, William D.
    SOUTHERN MEDICAL JOURNAL, 2015, 108 (04) : 224 - 228
  • [32] SPOP mutation as a predictive marker for treatment of metastatic castration-resistant prostate cancer.
    Stangl, Andrew
    Willner, Christopher
    Maahs, Lucas
    Burmeister, Charlotte
    Hwang, Clara
    Pilling, Amanda
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [33] Salvage chemotherapy with cisplatin, ifosfamide, and paclitaxel in metastatic castration-resistant prostate cancer.
    Von Amsberg, Gunhild
    Zilles, Mirjam
    Gild, Philipp
    Alsdorf, Winfried
    Boeckelmann, Lukas
    Langebrake, Claudia
    Oh-Hohenhorst, Su Jung
    Tilki, Derya
    Graefen, Markus
    Dyshlovoy, Sergey
    Bokemeyer, Carsten
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [34] Metastatic castration-resistant prostate cancer. Position paper for structured therapy monitoring
    Miller, K.
    Albers, P.
    Eichenauer, R.
    Geiges, G.
    Grimm, M. -O.
    Koenig, F.
    Mickisch, G.
    Pfister, D.
    Schwentner, C.
    Suttmann, H.
    Zastrow, S.
    UROLOGE, 2014, 53 (05): : 710 - 714
  • [35] Risk factors for progression to castration-resistant prostate cancer in metastatic prostate cancer patients
    Lin, Ting-Ting
    Chen, Ye-Hui
    Wu, Yu-Peng
    Chen, Shao-Zhan
    Li, Xiao-Dong
    Lin, Yun-Zhi
    Chen, Shao-Hao
    Zheng, Qing-Shui
    Wei, Yong
    Xu, Ning
    Xue, Xue-Yi
    JOURNAL OF CANCER, 2019, 10 (22): : 5608 - 5613
  • [36] A phase 2 study of immunogenic cell death inducer PT-112 in patients with metastatic castration-resistant prostate cancer.
    Bryce, Alan Haruo
    Karp, Daniel D.
    Tagawa, Scott T.
    Nordquist, Luke T.
    Rathkopf, Dana E.
    Adra, Nabil
    Dorff, Tanya B.
    Baeck, Johan
    O'Donnell, Joseph Francis
    Ames, Tyler David
    Yim, Christina Y.
    Price, Matthew
    Scher, Howard I.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [37] PSA surge in patients with castration-resistant prostate cancer receiving docetaxel.
    Tabata, Ken-ichi
    Satoh, Takefumi
    Matsumoto, Kazumasa
    Fujita, Tetsuo
    Iwamura, Masatsugu
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [38] Circadian gene expression in metastatic sites and association with survival in metastatic castration-resistant prostate cancer.
    Booker, Benjamin D.
    Stopsack, Konrad H.
    Gerke, Travis A.
    Penny, Kathryn
    Kantoff, Philip W.
    Mucci, Lorelei A.
    Markt, Sarah C.
    CANCER RESEARCH, 2021, 81 (13)
  • [39] Lipidomic profiling in patients with heavily pretreated castration-resistant prostate cancer.
    Cattrini, Carlo
    Manfredi, Marcello
    Barboro, Paola
    Ghirimoldi, Marco
    Mennitto, Alessia
    Martini, Veronica
    Biello, Federica
    D'Avanzo, Francesca
    Platini, Francesca
    Maggiora, Paola Maria
    Branni, Carmen
    Rua, Alessia
    Diprima, Santo
    Tassone, Andrea
    Gobbato, Simone
    Stella, Arianna
    Zanardi, Elisa
    Pinato, David James
    Boccardo, Francesco
    Gennari, Alessandra
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [40] Low hemoglobin and PSA kinetics are prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients
    Yuji Hakozaki
    Yuta Yamada
    Yuta Takeshima
    Satoru Taguchi
    Taketo Kawai
    Masaki Nakamura
    Takuya Iwaki
    Taro Teshima
    Yoshitaka Kinoshita
    Yoshiyuki Akiyama
    Yusuke Sato
    Daisuke Yamada
    Motofumi Suzuki
    Haruki Kume
    Scientific Reports, 13
12345